We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
-16.58%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$13.7M
AUM Growth
-$17.9M
(-57%)
Cap. Flow
-$15.1M
Cap. Flow
% of AUM
-110.13%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
22
New
3
Increased
1
Reduced
2
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BBNX
Beta Bionics
BBNX
|
+$8M |
| 2 |
KMTS
Kestra Medical Technologies
KMTS
|
+$919K |
| 3 |
IMDX
Insight Molecular Diagnostics
IMDX
|
+$791K |
| 4 |
Outset Medical
OM
|
+$59.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AdvisorShares Pure US Cannabis ETF
MSOS
|
+$2.86M |
| 2 |
Pulmonx
LUNG
|
+$2.63M |
| 3 |
Establishment Labs
ESTA
|
+$2.54M |
| 4 |
Quanterix
QTRX
|
+$2.5M |
| 5 |
CUTR
Cutera, Inc.
CUTR
|
+$403K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBNX
1
Beta Bionics
BBNX
$715M
| $5.25M | 38.36% |
+429,120
| New | +$8M |
|
|
IMDX
2
Insight Molecular Diagnostics
IMDX
$156M
| $2.9M | 21.17% |
947,134
+292,683
| +45% | +$791K |
|
|
3
Establishment Labs
ESTA
$2.28B
| $1.84M | 13.41% |
45,000
-68,041
| -60% | -$2.54M |
|
4
InspireMD
NSPR
$34.7M
| $1.21M | 8.85% |
450,517
| – | – |
|
|
KMTS
5
Kestra Medical Technologies
KMTS
$1.55B
| $997K | 7.28% |
+40,000
| New | +$919K |
|
|
6
Outset Medical
OM
$90.8M
| $783K | 5.72% |
+5,000
| New | +$59.6K |
|
7
Metagenomi Therapeutics
MGX
$46.3M
| $360K | 2.63% |
264,391
| – | – |
|
8
Natera
NTRA
$46.4B
| $354K | 2.58% |
2,500
-2,500
| -50% | -$402K |
|
9
CALL
Bioventus
BVS
$1.19B
| – | – |
-150,000
| Closed | -$1.57M |
|
10
CALL
Castle Biosciences
CSTL
$979M
| – | – |
-25,000
| Closed | -$666K |
|
11
CALL
Glaukos
GKOS
$10.6B
| – | – |
-12,000
| Closed | -$1.8M |
|
12
CALL
ICU Medical
ICUI
$4.61B
| – | – |
-10,000
| Closed | -$1.55M |
|
13
PUT
iShares US Medical Devices ETF
IHI
$3.38B
| – | – |
-20,000
| Closed | -$1.17M |
|
14
PUT
InMode
INMD
$880M
| – | – |
-50,000
| Closed | -$835K |
|
15
CALL
Intuitive Surgical
ISRG
$134B
| – | – |
-3,500
| Closed | -$1.83M |
|
|
16
Pulmonx
LUNG
$87.6M
| – | – |
-387,200
| Closed | -$2.63M |
|
|
17
AdvisorShares Pure US Cannabis ETF
MSOS
$880M
| – | – |
-750,000
| Closed | -$2.86M |
|
|
18
CALL
Natera
NTRA
$46.4B
| – | – |
-10,000
| Closed | -$1.58M |
|
19
PUT
VanEck Pharmaceutical ETF
PPH
$938M
| – | – |
-20,000
| Closed | -$1.73M |
|
|
20
CALL
Quanterix
QTRX
$190M
| – | – |
-75,000
| Closed | -$797K |
|
|
21
Quanterix
QTRX
$190M
| – | – |
-234,755
| Closed | -$2.5M |
|
|
CUTR
22
DELISTED
Cutera, Inc.
CUTR
| – | – |
-1,141,009
| Closed | -$403K |
|
Similar funds
BCA
ONGA
RC
DOFI
SR
SCI
LPC
GBCP
Pura Vida Investments's Q1 2025 Portfolio in Review
As of Q1 2025, Pura Vida Investments held 22 positions worth $13.7M, down 57% from $31.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Pura Vida Investments withdrew a net $15.1M in Q1 2025, closing 14 positions and reducing 2 holdings. Its most notable exit was AdvisorShares Pure US Cannabis ETF, an estimated $2.86M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 48% a quarter earlier.
Against the trend, Pura Vida Investments opened a new position in Beta Bionics worth $5.25M.
- Pura Vida Investments's largest Q1 2025 buy was Beta Bionics: 429,120 shares worth $5.25M.
- Pura Vida Investments added most to Insight Molecular Diagnostics in Q1 2025, an estimated $791K increase.
- Pura Vida Investments's biggest Q1 2025 reduction was Establishment Labs, cutting an estimated $2.54M.
- Pura Vida Investments fully exited AdvisorShares Pure US Cannabis ETF in Q1 2025, selling an estimated $2.86M.
- Pura Vida Investments's ten largest holdings make up 100% of its $13.7M portfolio in Q1 2025.
- Pura Vida Investments opened 3 new positions and closed 14 in Q1 2025.
- Pura Vida Investments's portfolio value fell 57% quarter-over-quarter to $13.7M.
Based on Pura Vida Investments's 13F filing for Q1 2025, filed 12 May 2025.